利用瘤微环境来促进采用T细胞疗法,用于固体瘤的工程淋巴细胞
Martina Spiga1, Elisa Martini1, Maria Chiara Maffia1
1Experimental Hematology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Seminars in immunopathology
|July 26, 2024
概括
采用细胞疗法 (ACT) 对血液癌症有希望,但与固体瘤斗争. 新的策略利用瘤微环境 (TME) 来增强CAR-T和TCR-T细胞疗法,以获得更好的结果.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 使用化学抗原受体 (CAR) 和T细胞受体 (TCR) 工程T细胞的采用细胞疗法 (ACT) 是治疗血液性恶性瘤的有效方法.
- 由于瘤微环境 (TME) 带来的挑战,其在固体瘤中的有效性仍然有限.
研究的目的:
- 探索克服TME诱导障碍的策略,以提高ACT在固体瘤中的有效性.
- 研究如何利用新的技术工具来提高TME内的CAR-T和TCR-T细胞性能.
主要方法:
- 审查ACT对固体瘤的当前挑战,包括TME内的物理障碍和抑制信号.
- 检查结合ACT与化疗/放射治疗和检查点抑制剂的协同方法.
- 研究用于TME调制和T细胞增强的先进技术工具.
主要成果:
- TME对ACT构成显著的物理和免疫障碍,影响T细胞功能.
- 将ACT与其他疗法结合起来可以缓解一些与TME相关的障碍.
- 新兴技术提供了利用或克服TME特征的方法,以促进T细胞的定位,生存和功能.
结论:
- 克服TME障碍对于成功的实体瘤ACT至关重要.
- 创新的方法,包括利用化学激素梯度,整合素表达,代谢重编程和合成受体,具有显著的潜力来增强CAR-T和TCR-T细胞疗法.
更多相关视频
09:12Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
Published on: June 14, 2024
874
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
697
相关概念视频
Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
